Table of Contents 1 Study Coverage 1.1 Biologic Drugs Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Biologic Drugs Market Size Growth Rate by Type 1.4.2 Humira 1.4.3 Remicade 1.4.4 Rituxan 1.4.5 Enbrel 1.4.6 Lantus 1.4.7 Avastin 1.4.8 Herceptin 1.4.9 Others 1.5 Market by Application 1.5.1 Global Biologic Drugs Market Size Growth Rate by Application 1.5.2 Diabetes 1.5.3 Inflammation 1.5.4 Auto-Immune Diseases 1.5.5 Blood Diseases 1.5.6 Cardiovascular Diseases 1.5.7 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Biologic Drugs Market Size 2.1.1 Global Biologic Drugs Revenue 2016-2025 2.1.2 Global Biologic Drugs Sales 2016-2025 2.2 Biologic Drugs Growth Rate by Regions 2.2.1 Global Biologic Drugs Sales by Regions 2.2.2 Global Biologic Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Biologic Drugs Sales by Manufacturers 3.1.1 Biologic Drugs Sales by Manufacturers 3.1.2 Biologic Drugs Sales Market Share by Manufacturers 3.1.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Biologic Drugs Revenue by Manufacturers 3.2.1 Biologic Drugs Revenue by Manufacturers (2016-2018) 3.2.2 Biologic Drugs Revenue Share by Manufacturers (2016-2018) 3.3 Biologic Drugs Price by Manufacturers 3.4 Biologic Drugs Manufacturing Base Distribution, Product Types 3.4.1 Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Biologic Drugs Product Category 3.4.3 Date of International Manufacturers Enter into Biologic Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Biologic Drugs Sales by Type 4.2 Global Biologic Drugs Revenue by Type 4.3 Biologic Drugs Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Biologic Drugs Breakdown Data by Application 6 North America 6.1 North America Biologic Drugs by Countries 6.1.1 North America Biologic Drugs Sales by Countries 6.1.2 North America Biologic Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Biologic Drugs by Type 6.3 North America Biologic Drugs by Application 6.4 North America Biologic Drugs by Company 7 Europe 7.1 Europe Biologic Drugs by Countries 7.1.1 Europe Biologic Drugs Sales by Countries 7.1.2 Europe Biologic Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Biologic Drugs by Type 7.3 Europe Biologic Drugs by Application 7.4 Europe Biologic Drugs by Company 8 Asia Pacific 8.1 Asia Pacific Biologic Drugs by Countries 8.1.1 Asia Pacific Biologic Drugs Sales by Countries 8.1.2 Asia Pacific Biologic Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Biologic Drugs by Type 8.3 Asia Pacific Biologic Drugs by Application 8.4 Asia Pacific Biologic Drugs by Company 9 Central & South America 9.1 Central & South America Biologic Drugs by Countries 9.1.1 Central & South America Biologic Drugs Sales by Countries 9.1.2 Central & South America Biologic Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Biologic Drugs by Type 9.3 Central & South America Biologic Drugs by Application 9.4 Central & South America Biologic Drugs by Company 10 Middle East and Africa 10.1 Middle East and Africa Biologic Drugs by Countries 10.1.1 Middle East and Africa Biologic Drugs Sales by Countries 10.1.2 Middle East and Africa Biologic Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Biologic Drugs by Type 10.3 Middle East and Africa Biologic Drugs by Application 10.4 Middle East and Africa Biologic Drugs by Company 11 Company Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.1.4 Biologic Drugs Product Description 11.1.5 Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.2.4 Biologic Drugs Product Description 11.2.5 Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.3.4 Biologic Drugs Product Description 11.3.5 Recent Development 11.4 Merck & Co. 11.4.1 Merck & Co. Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.4.4 Biologic Drugs Product Description 11.4.5 Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.5.4 Biologic Drugs Product Description 11.5.5 Recent Development 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.6.4 Biologic Drugs Product Description 11.6.5 Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.7.4 Biologic Drugs Product Description 11.7.5 Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.8.4 Biologic Drugs Product Description 11.8.5 Recent Development 11.9 Eli Lilly 11.9.1 Eli Lilly Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.9.4 Biologic Drugs Product Description 11.9.5 Recent Development 11.10 Amgen 11.10.1 Amgen Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Biologic Drugs 11.10.4 Biologic Drugs Product Description 11.10.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Biologic Drugs Raw Material 13.1.2 Biologic Drugs Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

List of Tables and Figures Figure Picture of Biologic Drugs Figure Global Biologic Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Biologic Drugs Production Market Share by Types (Product Category) in 2017 Figure Humira Product Picture Table Major Manufacturers of Humira Figure Remicade Product Picture Table Major Manufacturers of Remicade Figure Rituxan Product Picture Table Major Manufacturers of Rituxan Figure Enbrel Product Picture Table Major Manufacturers of Enbrel Figure Lantus Product Picture Table Major Manufacturers of Lantus Figure Avastin Product Picture Table Major Manufacturers of Avastin Figure Herceptin Product Picture Table Major Manufacturers of Herceptin Figure Others Product Picture Table Major Manufacturers of Others Table Global Biologic Drugs Market Size Growth Rate by Application 2018-2025 (K Units) Figure Diabetes Figure Inflammation Figure Auto-Immune Diseases Figure Blood Diseases Figure Cardiovascular Diseases Figure Others Figure Biologic Drugs Report Years Considered Figure Global Biologic Drugs Market Size 2016-2025 (Million US$) Figure Global Biologic Drugs Sales 2016-2025 (K Units) Table Global Biologic Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$) Table Global Biologic Drugs Sales by Regions 2016-2025 (K Units) Table Global Biologic Drugs Sales Market Share by Regions 2016-2025 Figure Global Biologic Drugs Sales Market Share by Regions 2016-2025 Figure 2017 Global Biologic Drugs Sales Market Share by Regions Table Global Biologic Drugs Revenue by Regions 2016-2025 (Million US$) Table Global Biologic Drugs Revenue Market Share by Regions 2016-2025 Figure Global Biologic Drugs Revenue Market Share by Regions 2016-2025 Figure 2017 Global Biologic Drugs Revenue Market Share by Regions Table Global Biologic Drugs Sales by Manufacturers (2016-2018) (K Units) Table Global Biologic Drugs Sales Share by Manufacturers (2016-2018) Figure Global Biologic Drugs Sales Share by Manufacturers in 2017 Table Biologic Drugs Revenue by Manufacturers (2016-2018) (Million US$) Table Biologic Drugs Revenue Share by Manufacturers (2016-2018) Figure Biologic Drugs Value Share by Manufacturers in 2017 Table Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Biologic Drugs Price (2016-2018) (USD/Unit) Table Biologic Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Biologic Drugs Product Category Table Date of International Manufacturers Enter into Biologic Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Biologic Drugs Sales by Type (2016-2025) (K Units) Table Global Biologic Drugs Sales Share by Type (2016-2025) Figure Global Biologic Drugs Sales Market Share by Type (2016-2025) Figure Global Biologic Drugs Sales Market Share by Type in 2017 Table Global Biologic Drugs Revenue by Type (2016-2025) (Million US$) Table Global Biologic Drugs Revenue Share by Type (2016-2025) Figure Global Biologic Drugs Revenue Market Share by Type (2016-2025) Figure Global Biologic Drugs Revenue Market Share by Type in 2017 Table Biologic Drugs Price by Type 2013-2018 (USD/Unit) Table Global Biologic Drugs Sales by Application (2016-2025) (K Units) Table Global Biologic Drugs Sales Share by Application (2016-2025) Figure Global Sales Biologic Drugs Market Share by Application (2016-2025) Figure Global Sales Biologic Drugs Market Share by Application (2016-2025) Figure North America Biologic Drugs Sales Growth Rate 2016-2025 (K Units) Figure North America Biologic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table North America Biologic Drugs Sales by Countries (2016-2025) (K Units) Table North America Biologic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 North America Biologic Drugs Sales Market Share by Countries Table North America Biologic Drugs Revenue by Countries (2016-2025) (Million US$) Table North America Biologic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 North America Biologic Drugs Revenue Market Share by Countries Figure United States Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure United States Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Canada Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Mexico Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table North America Biologic Drugs Sales by Type (2016-2025) (K Units) Table North America Biologic Drugs Sales Market Share by Type (2016-2025) Figure 2017 North America Biologic Drugs Market Share by Type Table North America Biologic Drugs Sales by Application (2016-2025) (K Units) Table North America Biologic Drugs Sales Market Share by Application (2016-2025) Figure 2017 North America Biologic Drugs Market Share by Application Table North America Biologic Drugs Sales by Company (2016-2018) (K Units) Table North America Biologic Drugs Sales Market Share by Company (2016-2018) Figure North America Biologic Drugs Sales Market Share by Company in 2017 Figure Europe Biologic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Europe Biologic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Europe Biologic Drugs Sales by Countries (2016-2025) (K Units) Table Europe Biologic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Europe Biologic Drugs Sales Market Share by Countries Table Europe Biologic Drugs Revenue by Countries (2016-2025) (Million US$) Table Europe Biologic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Biologic Drugs Revenue Market Share by Countries Figure Germany Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Germany Biologic Drugs Revenue Growth Rate (2016-2025) (K Units) Figure France Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure France Biologic Drugs Revenue Growth Rate (2016-2025) (K Units) Figure UK Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure UK Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Italy Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Russia Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Europe Biologic Drugs Sales by Type (2016-2025) (K Units) Table Europe Biologic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Europe Biologic Drugs Market Share by Type Table Europe Biologic Drugs Sales by Application (2016-2025) (K Units) Table Europe Biologic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Europe Biologic Drugs Market Share by Application Table Europe Biologic Drugs Sales by Company (2016-2018) (K Units) Table Europe Biologic Drugs Sales Market Share by Company (2016-2018) Figure Europe Biologic Drugs Sales Market Share by Company in 2017 Figure Asia Pacific Biologic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Asia Pacific Biologic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Biologic Drugs Sales by Countries (2016-2025) (K Units) Table Asia Pacific Biologic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Biologic Drugs Sales Market Share by Countries Table Asia Pacific Biologic Drugs Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Biologic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Biologic Drugs Revenue Market Share by Countries Figure China Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure China Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Japan Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Korea Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure India Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure India Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Australia Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Indonesia Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Malaysia Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Philippines Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Thailand Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Vietnam Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Singapore Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Biologic Drugs Sales by Type (2016-2025) (K Units) Table Asia Pacific Biologic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Biologic Drugs Market Share by Type Table Asia Pacific Biologic Drugs Sales by Application (2016-2025) (K Units) Table Asia Pacific Biologic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Biologic Drugs Market Share by Application Table Asia Pacific Biologic Drugs Sales by Company (2016-2018) (K Units) Table Asia Pacific Biologic Drugs Sales Market Share by Company (2016-2018) Figure Asia Pacific Biologic Drugs Sales Market Share by Company in 2017 Figure Central & South America Biologic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Central & South America Biologic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Biologic Drugs Sales by Countries (2016-2025) (K Units) Table Central & South America Biologic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Biologic Drugs Sales Market Share by Countries Table Central & South America Biologic Drugs Revenue by Countries (2016-2025) (Million US$) Table Central & South America Biologic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Biologic Drugs Revenue Market Share by Countries Figure Brazil Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Brazil Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Argentina Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Biologic Drugs Sales by Type (2016-2025) (K Units) Table Central & South America Biologic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Biologic Drugs Market Share by Type Table Central & South America Biologic Drugs Sales by Application (2016-2025) (K Units) Table Central & South America Biologic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Biologic Drugs Market Share by Application Table Central & South America Biologic Drugs Sales by Company (2016-2018) (K Units) Table Central & South America Biologic Drugs Sales Market Share by Company (2016-2018) Figure Central & South America Biologic Drugs Sales Market Share by Company in 2017 Figure Middle East and Africa Biologic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Middle East and Africa Biologic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Biologic Drugs Sales by Countries (2016-2025) (K Units) Table Middle East and Africa Biologic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Biologic Drugs Sales Market Share by Countries Table Middle East and Africa Biologic Drugs Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Biologic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Biologic Drugs Revenue Market Share by Countries Figure GCC Countries Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure GCC Countries Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Turkey Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Egypt Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Biologic Drugs Sales Growth Rate (2016-2025) (K Units) Figure South Africa Biologic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Biologic Drugs Sales by Type (2016-2025) (K Units) Table Middle East and Africa Biologic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Biologic Drugs Market Share by Type Table Middle East and Africa Biologic Drugs Sales by Application (2016-2025) (K Units) Table Middle East and Africa Biologic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Biologic Drugs Market Share by Application Table Middle East and Africa Biologic Drugs Sales by Company (2016-2018) (K Units) Table Middle East and Africa Biologic Drugs Sales Market Share by Company (2016-2018) Figure Middle East and Africa Biologic Drugs Sales Market Share by Company in 2017 Table Roche Company Details Table Roche Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Roche Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Abbott Laboratories Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Johnson & Johnson Recent Development Table Merck & Co. Company Details Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Merck & Co. Recent Development Table Pfizer Company Details Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Pfizer Recent Development Table Amgen Company Details Table Amgen Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Amgen Recent Development Table Sanofi Company Details Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Sanofi Recent Development Table Novartis Company Details Table Novartis Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Novartis Recent Development Table Eli Lilly Company Details Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Eli Lilly Recent Development Table Amgen Company Details Table Amgen Biologic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Amgen Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Biologic Drugs Value Chain Table Typical Suppliers of Key Biologic Drugs Raw Material Table Biologic Drugs Customers List Table Biologic Drugs Sales Channels Table Biologic Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources